Gsa Capital Partners LLP Teva Pharmaceutical Industries LTD Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$7.33 - $9.39 $116,422 - $149,141	-15,883 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $125,475 - $161,847	15,883 New	15,883 $127,000
Q3 2020 Nov 06, 2020	SELL	$8.57 - $12.69 $113,124 - $167,508	-13,200 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$8.12 - $13.12 $107,183 - $173,184	13,200 New	13,200 $163,000
Q1 2020 May 12, 2020	SELL	$6.69 - $13.45 $105,735 - $212,577	-15,805 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$6.53 - $10.72 $36,326 - $59,635	-5,563 Reduced 26.03%	15,805 $155,000
Q3 2019 Nov 12, 2019	BUY	$6.16 - $9.6 $131,626 - $205,132	21,368 New	21,368 $147,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.